This study corroborates a previous one showing the immunohistochemical expression of both NG2 and PDGFRα in various glioma types including pilocytic astrocytoma, GBM and other diffuse gliomas classified at this time as “oligodendroglioma “and “fibrillary astrocytoma” [85]. Here, PDGFRA is linked to central nervous system cancer.